Researchers found that both CBEs and ABEs can cause transcriptome-wide RNA edits, which has implications for the research and therapeutic uses of base editors.
A Stanford University investigation finds that its researchers did not take part in He Jiankui's work to develop gene-edited infants.
NPR's Morning Edition reports that a number of CRISPR-based gene editing treatments are to be tested soon in humans in the US.
The team reported that engineering a hairpin secondary structure onto the spacer region of sgRNAs can increase specificity by several orders of magnitude.
Stanford University's Stephen Quake tells the New York Times that he encouraged CRISPR researcher He Jiankui to seek the proper ethical approvals.
The researchers created a resource of cancer dependencies and developed a framework to prioritize existing cancer drug targets and suggest new ones.
Science reports that researchers have found a way to use CRISPR on lizard embryos.
In PLOS this week: 'reverse genome-wide association study' method; genetic links between Familial Mediterranean Fever and ankylosing spondylitis; and more.
Centene will contribute up to $100 million over 10 years to fund research into Alzheimer's disease, breast cancer, diabetes, and obesity at WashU.
In Science this week: genomic study of convergent evolution of the loss of flight in birds, and more.
Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.
St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.
St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.
In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.